What does this research mean for the field?

miR-105-1 is downregulated in hepatocellular carcinoma, and its low expression, combined with high expression of its direct target NCOA1, correlates with poor clinical prognosis. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 2, 2017OncotargetOpen Access

High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1

View Full Paper

Ask AI

Bookmark

Authors

YMYu‐Shui MaRenji Hospital TWTing‐Miao WuAnhui Medical University ZLZhongwei LvShanxi University

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ma et al. (2017) studied this question.

synapsesocial.com/papers/6aa95acdda0b4bae44461e0d https://doi.org/10.18632/oncotarget.14435

View Full Paper

Ask AI

Bookmark

January 2, 2017OncotargetOpen Access

High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1

View Full Paper

Ask AI

Bookmark

Authors

YMYu‐Shui MaRenji Hospital TWTing‐Miao WuAnhui Medical University ZLZhongwei LvShanxi University

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ma et al. (2017) studied this question.

synapsesocial.com/papers/6aa95acdda0b4bae44461e0d https://doi.org/10.18632/oncotarget.14435

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark